WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for JANX

Based on 2 analysts offering 12 month price targets for Janux Therapeutics Inc.
Min Forecast
$24.00+141.45%
Avg Forecast
$29.50+196.78%
Max Forecast
$35.00+252.11%

Should I buy or sell JANX stock?

Based on 2 analysts offering ratings for Janux Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their JANX stock forecasts and price targets.

JANX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Wedbush
Bottom 6%
6
BuyReiterates$24.00+141.45%2023-08-10
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$35.00+252.11%2023-08-09

1 of 1

Forecast return on equity

Is JANX forecast to generate an efficient return?
Company
-48.38%
Industry
30.23%
Market
58.27%
JANX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JANX forecast to generate an efficient return on assets?
Company
-42.42%
Industry
12.08%
JANX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JANX revenue growth forecast

How is JANX forecast to perform vs Biotechnology companies and vs the US market?
Company
342.04%
Industry
58.79%
Market
7.89%
JANX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JANX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JANX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JANX$9.94$29.50+196.78%Buy
IGMS$7.72$20.67+167.71%Buy
URGN$15.44$31.33+102.93%Buy
TBPH$8.90$20.00+124.72%Buy
RNA$6.38$31.60+395.30%Strong Buy
View Top Biotech Stocks

Janux Therapeutics Stock Forecast FAQ

Is Janux Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: JANX) stock is to Buy JANX stock.

Out of 2 analysts, 0 (0%) are recommending JANX as a Strong Buy, 2 (100%) are recommending JANX as a Buy, 0 (0%) are recommending JANX as a Hold, 0 (0%) are recommending JANX as a Sell, and 0 (0%) are recommending JANX as a Strong Sell.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.

What is JANX's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: JANX) forecast ROE is -48.38%, which is considered weak.

What is JANX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year JANX price target, the average JANX price target is $29.50, with the highest JANX stock price forecast at $35.00 and the lowest JANX stock price forecast at $24.00.

On average, Wall Street analysts predict that Janux Therapeutics's share price could reach $29.50 by Aug 10, 2024. The average Janux Therapeutics stock price prediction forecasts a potential upside of 196.78% from the current JANX share price of $9.94.

What is JANX's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: JANX) forecast ROA is -42.42%, which is lower than the forecast US Biotechnology industry average of 12.08%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.